Mutation in Abl kinase with altered drug binding kinetics indicates a novel mechanism of imatinib resistance is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2021). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 1S10OD028478-01
Robotic assay platform
National Institutes of Health
Grant: 5R01GM121505-02
The role of reorganization energy in achieving selective kinase inhibition
National Institutes of Health
Grant: 2T32GM008444-24
Medical Scientist Training Program
European Commission
Grant: 875510
EUbOPEN: Enabling and Unlocking biology in the OPEN
National Institutes of Health
Grant: 2P30CA008748-43
MOUSE GENETICS
National Institutes of Health
Grant: 3R35GM119437-09S1
Dynamics of Ligand Binding and Protein Kinase Regulation
National Institutes of Health
Grant: 5F30CA260771-02
Elucidating the Role of Binding Kinetics in the Development of Abl Kinase Drug Resistance
National Institutes of Health
Grant: 5F30CA225172-04
Understanding how patient-derived resistance mutations affect the process of imatinib binding to Abl kinase
Fields of Study
Keywords
Sustainable Development Goals